ducovest

VIOV:NYE-Vanguard S&P Small-Cap 600 Value Index Fund ETF Shares (USD)

ETF | Small Value |

Last Closing

USD 92.64

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

N/A

 USD 29.87B
IJS iShares S&P Small-Cap 600 Valu..

N/A

 USD 7.07B
DES WisdomTree U.S. SmallCap Divid..

N/A

 USD 2.01B
XSVM Invesco S&P SmallCap Value wit..

N/A

 USD 0.80B
XSLV Invesco S&P SmallCap Low Volat..

N/A

 USD 0.33B
RFV Invesco S&P MidCap 400® Pure ..

N/A

 N/A
SLYV SPDR® S&P 600 Small Cap Value..

N/A

 N/A
FDM First Trust Dow Jones Select M..

N/A

 N/A
RWJ Invesco S&P SmallCap 600 Reven..

N/A

 N/A
RZV Invesco S&P SmallCap 600® Pur..

N/A

 N/A

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.68% 64% D 42% F
Dividend Return 0.23% 9% A- 4% F
Total Return 4.90% 36% F 32% F
Trailing 12 Months  
Capital Gain 19.91% 25% F 62% D
Dividend Return 1.69% 58% F 28% F
Total Return 21.60% 25% F 58% F
Trailing 5 Years  
Capital Gain 40.89% 42% F 67% D+
Dividend Return 8.87% 75% C 30% F
Total Return 49.75% 50% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 13.02% 58% F 74% C
Dividend Return 14.73% 58% F 74% C
Total Return 1.70% 83% B 39% F
Risk Return Profile  
Volatility (Standard Deviation) 31.64% 58% F 32% F
Risk Adjusted Return 46.54% 50% F 64% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.